Experience with the use of an intranasal LHRH analogue for the induction of puberty.
7 patients aged 16-25 years with hypogonadotrophic hypogonadism have been treated with 100 micrograms of a synthetic gonadotrophin-releasing hormone intranasal spray (HOE 766) on alternate days. In 1 patient, after an encouraging initial response there was a rapid decline in gonadotrophin responsiveness. 3 patients failed to show biochemical or clinical effects of treatment. 3 cases showed continuing responsiveness of gonadotrophin sex steroid levels to treatment for periods between 8 and 11 months.